Thus, in line with our findings that NLRP3 and ASC (Pycard) deficient mice were protected against obesity-induced metabolic dysfunction (Figure 3), these mice were also able to suppress development of hepatic steatosis during HFD. Here, NLRP3 is linked to obesity due to melanocortin 4 receptor deficiency.